Detalhe da pesquisa
1.
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease.
Mol Ther Oncolytics
; 18: 504-524, 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32953984